Audited Supplier
736992-21-5
736992-21-5
C32h49n9o5
Lyophilized Powder
Powder
There Are No Other Peptides Like Ss-31 in The Worl
White
Purity HPLC
-20°c, Protect From Light, Dry, Sealed
639.8 G/Mol
48h
GMP
Box/Kit/Tube
25mg
China
Product Description
Elamipretide(SS31) is a new tetrapeptide that targets and stabilizes mitochondrial cardiolipin, improves multiple functional aspects of mitochondria derived from explanted human failing hearts, and reverses cardiac mitochondrial abnormalities and LV remodeling in a canine model of HFrEF.
SS-31 is a synthetic peptide that improves mitochondrial function and is currently undergoing clinical trials for treatments of heart failure, primary mitochondrial myopathy, and other mitochondrial diseases. Also known as Bendavia or elamipretide, is a mitochondria-targeting peptide that accumulates in mitochondria and scavenges reactive oxygen species. It's a small, cell-permeable molecule that selectively targets the inner mitochondrial membrane, where it interacts with cardiolipin, a key phospholipid component. This interaction helps stabilize mitochondrial membranes, optimize electron transport chain function, and mitigate oxidative stress.
SS-31 PEPTIDE BENEFITS
- Mitochondrial Protection: SS-31 enhances the structural integrity and function of mitochondria, protecting them from damage caused by oxidative stress, a major contributor to various diseases and aging processes.
- Energy Production: By preserving mitochondrial function, SS-31 promotes efficient ATP production through the electron transport chain, supporting cellular energy metabolism.
- Anti-inflammatory Effects: SS-31 has been shown to reduce inflammation by inhibiting the release of pro-inflammatory cytokines and dampening the activation of inflammatory pathways within cells.
- Cardioprotection: Studies have demonstrated the cardioprotective effects of SS-31, including its ability to improve cardiac function, reduce ischemia/reperfusion injury, and enhance recovery after heart attacks.
- Neuroprotection: SS-31 shows promise in protecting neurons from oxidative damage and improving mitochondrial function in neurodegenerative diseases such as Alzheimer's and Parkinson's.
Zhaobo Bio acquired early mastery of development and manufacturing of peptides, the short chain amino acids linked by peptide bonds that have enabled new generations of small molecule drugs that closely mimic the body's natural pathways.
Now Zhaobo Bio possesses first-class capabilities to manufacture peptides at industrial scale and in full compliance with the strictest Good Manufacturing Practice (cGMP) standards.Upstream peptide synthesis.
Now Zhaobo Bio possesses first-class capabilities to manufacture peptides at industrial scale and in full compliance with the strictest Good Manufacturing Practice (cGMP) standards.Upstream peptide synthesis.
